In the last trading session, 3.21 million shares of the Clover Health Investments Corp (NASDAQ:CLOV) were traded, and its beta was 2.00. Most recently the company’s share price was $4.38, and it changed around $0.06 or 1.39% from the last close, which brings the market valuation of the company to $2.19B. CLOV currently trades at a discount to its 52-week high of $4.87, offering almost -11.19% off that amount. The share price’s 52-week low was $0.61, which indicates that the current value has risen by an impressive 86.07% since then. We note from Clover Health Investments Corp’s average daily trading volume that its 10-day average is 6.16 million shares, with the 3-month average coming to 5.86 million.
Clover Health Investments Corp stock received a consensus recommendation rating of Buy, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 2 recommended CLOV as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Clover Health Investments Corp is expected to report earnings per share of -0.06 for the current quarter.
Clover Health Investments Corp (NASDAQ:CLOV) trade information
Instantly CLOV has showed a green trend with a performance of 1.39% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 4.66 on recent trading dayincreased the stock’s daily price by 6.01%. The company’s shares are currently up 39.05% year-to-date, but still up 1.62% over the last five days. On the other hand, Clover Health Investments Corp (NASDAQ:CLOV) is 20.33% up in the 30-day period. We can see from the shorts that 16.42 million shares have been sold at a short interest cover period of 2.88 day(s).
The consensus price target as assigned by Wall Street analysts is $6, which translates to bulls needing to increase their stock price by 27.0% from its current value. Analyst projections state that CLOV is forecast to be at a low of $6 and a high of $6.
Clover Health Investments Corp (CLOV) estimates and forecasts
The year-over-year growth rate is expected to be -32.09%, down from the previous year.
Consensus estimates provided by 4 financial analysts predict the company will bring in an average of 346.92M in revenue for the current quarter. 4 analysts expect Clover Health Investments Corp to make 397.59M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 510.25M and 346.92M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -32.01%. Forecasts for the next quarter put sales growth at 14.60%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -585.84%. Clover Health Investments Corp earnings are expected to increase by 73.20% in 2025, but the outlook is positive 46.63% per year for the next five years.
CLOV Dividends
Clover Health Investments Corp’s next quarterly earnings report is expected to be released in March.
Clover Health Investments Corp (NASDAQ:CLOV)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 5.21% of Clover Health Investments Corp shares, and 20.21% of them are in the hands of institutional investors. The stock currently has a share float of 21.32%. Clover Health Investments Corp stock is held by 194.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 3.5662% of the shares, which is about 17.35 million shares worth $21.33 million.
RENAISSANCE TECHNOLOGIES LLC, with 2.3176% or 11.27 million shares worth $13.86 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
